<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00802269</url>
  </required_header>
  <id_info>
    <org_study_id>APEC-032</org_study_id>
    <nct_id>NCT00802269</nct_id>
  </id_info>
  <brief_title>Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy.</brief_title>
  <official_title>Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asociación para Evitar la Ceguera en México</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asociación para Evitar la Ceguera en México</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The used of reduced fluence parameters for panretinal photocoagulation decreases pain as
      perceived by the patient, compared to traditional parameters.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain (NRS-11 scale)</measure>
    <time_frame>Immediately post-treatment</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Proliferative Diabetic Retinopathy</condition>
  <arm_group>
    <arm_group_label>Reduced Fluence Parameters</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eyes receiving retinal photocoagulation with reduced fluence parameters (time 20-50 msec, power 400-700 mW)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional parameters</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Eyes receiving retinal photocoagulation with traditional parameters (time 100-200 msec, power 200-400 mW)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Retinal laser photocoagulation</intervention_name>
    <description>Retinal laser photocoagulation using a 532 nm laser</description>
    <arm_group_label>Reduced Fluence Parameters</arm_group_label>
    <arm_group_label>Traditional parameters</arm_group_label>
    <other_name>Alcon Eyelite 532 (doubled frequency Nd:Yag)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients 18 years or older, that signed informed consent

          -  Proliferative diabetic retinopathy with indication for panretinal photocoagulation

        Exclusion Criteria:

          -  Previous retinal photocoagulation

          -  Previous ocular surgical procedures

          -  Ocular media opacities

          -  History of trigeminal neuralgia

          -  Chronic ocular pain

          -  Depression under conductual or medical treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oscar Alvarez-Verduzco, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asociación para Evitar la Ceguera en México</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asociacion para Evitar la Ceguera en Mexico</name>
      <address>
        <city>Mexico City</city>
        <state>DF</state>
        <zip>04030</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>December 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 3, 2008</study_first_submitted>
  <study_first_submitted_qc>December 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2008</study_first_posted>
  <last_update_submitted>December 3, 2008</last_update_submitted>
  <last_update_submitted_qc>December 3, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2008</last_update_posted>
  <responsible_party>
    <name_title>Oscar Alvarez-Verduzco</name_title>
    <organization>Asociación para Evitar la Ceguera en México</organization>
  </responsible_party>
  <keyword>Proliferative diabetic retinopathy</keyword>
  <keyword>Laser photocoagulation</keyword>
  <keyword>Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

